Expedient synthesis of the heneicosasaccharyl mannose capped arabinomannan of the Mycobacterium tuberculosis cellular envelope by glycosyl carbonate donors

Chemical Science
Maidul IslamSrinivas Hotha


The global incidence of tuberculosis is increasing at an alarming rate, and Mycobacterium tuberculosis (Mtb) is the causative agent for tuberculosis, a disease with high mortality. Lipoarabinomannan (LAM) is one of the major components of the Mtb cellular envelope and is an attractive scaffold for developing anti-tubercular drugs, vaccines and diagnostics. Herein, a highly convergent strategy is developed to synthesize heneicosasaccharyl arabinomannan for the first time. The arabinomannan synthesized in this endeavour has several 1,2-trans or α-Araf linkages and three 1,2-cis or β-Araf linkages end capped with 1,2-trans or α-Manp linkages. All the key glycosidations were performed with alkynyl carbonate glycosyl donors under [Au]/[Ag] catalysis conditions, which gave excellent yields and stereoselectivity even for the reactions between complex and branched oligosaccharides. The resultant allyl oligosaccharide was globally deprotected to obtain the heneicosasaccharyl arabinomannan as a propyl glycoside. In summary, heneicosasaccharyl mannose capped arabinomannan synthesis was achieved in 56 steps with 0.016% overall yield.


Jan 1, 1995·Annual Review of Biochemistry·P J Brennan, H Nikaido
Nov 22, 1996·The Journal of Biological Chemistry·J LiuH Nikaido
Jan 20, 2004·Tropical Medicine & International Health : TM & IH·Richard J Coker
Feb 10, 2004·Frontiers in Bioscience : a Journal and Virtual Library·Mary Margaret Wade, Ying Zhang
Jul 27, 2006·Journal of the American Chemical Society·Srinivas Hotha, Sudhir Kashyap
Oct 10, 2006·The Journal of Organic Chemistry·Alexandra HölemannPeter H Seeberger
Sep 9, 2008·Trends in Microbiology·Gunilla KälleniusStefan B Svenson
Nov 8, 2008·The Journal of Organic Chemistry·Bert Fraser-ReidChangalvala V S Ramamurty
Jun 18, 2009·Chemical Communications : Chem Comm·Srinivasa Rao Vidadala, Srinivas Hotha
Sep 5, 2009·Advances in Applied Microbiology·Devinder KaurMary Jackson
Feb 19, 2010·Angewandte Chemie·Charles E Hoyle, Christopher N Bowman
Feb 4, 2011·Journal of the American Chemical Society·Akihiro Ishiwata, Yukishige Ito
Mar 9, 2011·The Journal of Organic Chemistry·Changalvala V S RamamurtyBert Fraser-Reid
Jun 14, 2012·Chemical Communications : Chem Comm·Abhijeet K Kayastha, Srinivas Hotha
Aug 3, 2012·Journal of the American Chemical Society·Brian H Northrop, Roderick N Coffey
Nov 30, 2012·Respirology : Official Journal of the Asian Pacific Society of Respirology·Keertan DhedaWing Cheong Yam
Jan 22, 2014·Organic Letters·Jian GaoZhongwu Guo
Jul 16, 2014·The Journal of Organic Chemistry·Shivaji A ThadkeSrinivas Hotha
May 16, 2015·Scientific Reports·Conrad E ChanPaul A MacAry
Jul 22, 2015·The Journal of Organic Chemistry·Maidul IslamSrinivas Hotha
Oct 29, 2015·The Journal of Organic Chemistry·Kamar Sahloul, Todd L Lowary

❮ Previous
Next ❯


Aug 2, 2017·Chemical Communications : Chem Comm·K NareshP H Seeberger
Dec 17, 2019·Beilstein Journal of Organic Chemistry·Alonso Pardo-VargasPeter H Seeberger
Apr 7, 2018·Journal of the American Chemical Society·Martina DelbiancoPeter H Seeberger
Aug 14, 2021·Beilstein Journal of Organic Chemistry·Giulio FittolaniMartina Delbianco
Oct 7, 2017·The Journal of Organic Chemistry·Mahesh NeralkarSrinivas Hotha
Jun 6, 2018·Chemical Reviews·Suvarn S KulkarniShang-Cheng Hung
Sep 10, 2019·ACS Omega·Pablo ValverdeJesús Jiménez-Barbero

❮ Previous
Next ❯

Methods Mentioned

column chromatography

Related Concepts

Related Feeds

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.